Pages that link to "Q34739207"

The following pages link to Microarrays as cancer keys: an array of possibilities. (Q34739207):

Displaying 37 items.

• Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model (Q24795055) (← links)
• Genetic alteration and gene expression modulation during cancer progression (Q24798750) (← links)
• Somatic mosaicism in the human genome (Q26823199) (← links)
• Nucleic acid microarrays: an overview (Q29304387) (← links)
• Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT). (Q33291060) (← links)
• 3'-end sequencing for expression quantification (3SEQ) from archival tumor samples (Q33526362) (← links)
• Standards affecting the consistency of gene expression arrays in clinical applications (Q33780759) (← links)
• Extensive up-regulation of gene expression in cancer: the normalised use of microarray data (Q34123325) (← links)
• TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer (Q34248613) (← links)
• Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. (Q34410542) (← links)
• Molecular profiling of hepatocellular carcinomas by cDNA microarray (Q34605680) (← links)
• Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology (Q35063647) (← links)
• Profiling cancer (Q35089389) (← links)
• Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model (Q35094438) (← links)
• Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms (Q35124775) (← links)
• Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways (Q35576159) (← links)
• Transcriptomic profiles differentiate normal rectal epithelium and adenocarcinoma (Q35676166) (← links)
• Genomic expression profiling and bioinformatics analysis of pancreatic cancer (Q35919898) (← links)
• Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway (Q36066191) (← links)
• Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle (Q36118431) (← links)
• ImmunoCell-Array: a novel technology for pathway discovery and cell profiling (Q36973770) (← links)
• Drug metabolism by tumours: its nature, relevance and therapeutic implications (Q37008879) (← links)
• A Comprehensive Guide to Sleeping Beauty-Based Somatic Transposon Mutagenesis in the Mouse (Q40841671) (← links)
• Extensive increase of microarray signals in cancers calls for novel normalization assumptions (Q43580446) (← links)
• Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy (Q44710572) (← links)
• Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma (Q44917659) (← links)
• Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis (Q47109892) (← links)
• Molecular analysis of transitional cell carcinoma using cDNA microarray (Q47612069) (← links)
• Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma (Q50938451) (← links)
• [Microarrays]. (Q53368385) (← links)
• Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. (Q53370638) (← links)
• Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy. (Q55514484) (← links)
• P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: A clinical/laboratory correlative analysis of RTOG-9003 (Q79124440) (← links)
• [Histopathologic validation of the tissue-microarray technology of urothelial cancer. Our experience] (Q80084235) (← links)
• Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder (Q84522692) (← links)
• Integrated bioinformatics analysis to identify 15 hub genes in breast cancer (Q92683580) (← links)
• EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy (Q99419149) (← links)